Quarterly report pursuant to Section 13 or 15(d)

Segment Reporting - Summary of Segment Performance (Details)

v3.20.2
Segment Reporting - Summary of Segment Performance (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Segment Reporting Information [Line Items]        
Net revenue $ 900 $ 2,153 $ 2,274 $ 3,901
Cost of revenue 1,167 2,733 2,751 4,675
Gross profit (loss) (267) (580) (477) (774)
Vascular [Member]        
Segment Reporting Information [Line Items]        
Net revenue 78 434 191 895
Cost of revenue 417 1,423 1,078 2,590
Gross profit (loss) (339) (989) (887) (1,695)
Dermatology [Member]        
Segment Reporting Information [Line Items]        
Net revenue 822 1,719 2,083 3,006
Cost of revenue 750 1,310 1,673 2,085
Gross profit (loss) $ 72 $ 409 $ 410 $ 921